What You Need to Know About Coronavirus - Monday, April 6

At first it looked like Singapore, Hong Kong, Taiwan, and SK had figured out how to contain Covid-19. But early success led some to loosen up. Now new cases are on the rise.

Bill Gates is spending billions to set up factories to make the seven most promising coronavirus vaccines. At most two will be made, but building manufacturing capacity now means they can be made quickly once they’re ready.

No sooner had Zoom become a work-from-home essential than its many privacy glitches came to light. From David Nield, here’s our guide to keeping your calls safe and secure.

Can the Defense Protection Act really be used to manufacture PPEs and keep hospitals functioning? Not exactly. Elias Groll on why it may be too late for the DPA to correct America’s critical supply shortage.

Because of insufficient testing, we still don’t know how far coronavirus has spread. Some researchers are analyzing wastewater to more accurately estimate the number of Covid-19 infections—and to detect the virus if it returns.

In 1998, a Fujifilm subsidiary developed a new antiviral compound. The resulting drug, Favipiravir, mitigated the effects of Ebola and showed promise in Wuhan. Now Japan hopes to use it to treat Covid-19.

Last Friday, Adam Rogers and I spent an hour answering reader questions about coronavirus. Our conversation covered everything from the science behind wearing a mask to the future of peer-reviewed research. Check it out here.

Migrant workers make up around 20% of India’s workforce. Trapped in cities far from home with no protections and dwindling resources, many have no idea how they’ll survive the country’s 21-day lockdown.

David Remnick in The New Yorker: “The vacancy of our public spaces, though antithetical to the purpose of a great city, which is defined by the constancy and the poetry of its encounters, is needed for its preservation.”